Pioneering cellular medicines for women’s health
We’re developing off-the-shelf cell therapies for high-impact women’s diseases, with lead programs in ovarian cancer, triple negative breast cancer and endometriosis.
Pioneering excellence in the field of immunotherapy
Cartherics creates precisely-defined immunotherapy treatments to combat a variety of cancers, endometriosis and Alzheimer’s disease. We combine the best components of immune targeting utilising gene editing and CAR technology to advance cell therapy to provide more diverse off-the-shelf treatments for patients. Our team has strong backgrounds in research, development, and product commercialisation. And we partner with leading commercial and academic groups with complementary technology to push the boundaries of cell therapy for cancer and beyond.
Some of our partners
Latest news
Cartherics CEO Alan Trounson gets pat on the back from the National Library of Australia
By Christine Filippis / August 9, 2021
By Leigh Dayton 9 August 2021 Cartherics is pleased to announce that CEO Alan Trounson has been congratulated by the...
Read More
Victorian development biologists are gathering in August & Cartherics joins the intellectual party
By Christine Filippis / July 22, 2021
By Leigh Dayton 22 July 2021 Cartherics is delighted to announce that it is a sponsor of the Australia and...
Read More
Cartherics, ARMI and CCRM Australia announce new agreement for closer cooperation and collaboration
By Christine Filippis / July 5, 2021
Cartherics Pty Ltd and the Australian Regenerative Medicine Institute (ARMI), including commercialisation initiative CCRM Australia, announced agreements for closer cooperation...
Read More
